CIK 0001849296
- Non-accelerated filer
- Emerging growth company
OKYO Pharma Ltd
Sign in to watch- Ticker
- OKYO
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- Entity type
- Other
- Phone
- +44 2074952379
- Business address
- 55 PARK LANE, LONDON, United Kingdom, W1K 1NA
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-07-27 | Patil Rajkumar V. Chief Scientific Officer | Purchase | +3,363 | $1.49 | $5K | 20,030 |
| 2026-07-27 | Patil Rajkumar V. Chief Scientific Officer | Grant or award | +3,363 | $1.49 | $5K | 20,030 |
| 2026-07-22 | Dempsey Robert John CHIEF EXECUTIVE OFFICER | Purchase | +15,000 | $1.54 | $23K | 15,000 |
| 2026-07-22 | Dempsey Robert John CHIEF EXECUTIVE OFFICER | Grant or award | +15,000 | $1.54 | $23K | 15,000 |
| 2026-07-21 | BRANCACCIO JOHN P Director | Purchase | +5,000 | $1.48 | $7K | 35,201 |
| 2026-07-21 | JACOB GARY S CHIEF DEVELOPMENT OFFICER | Purchase | +3,500 | $1.40 | $5K | 112,420 |
| 2026-07-21 | Mantelli Flavio CHIEF MEDICAL OFFICER | Purchase | +20,000 | $1.40 | $28K | 20,000 |
| 2026-07-21 | CERRONE GABRIELE M Director | Purchase | +22,500 | $1.45 | $33K | 10,873,916 |
| 2026-07-21 | CERRONE GABRIELE M Director | Grant or award | +22,500 | $1.45 | $33K | 10,873,916 |
| 2026-07-21 | JACOB GARY S CHIEF DEVELOPMENT OFFICER | Grant or award | +3,500 | $1.40 | $5K | 112,420 |
| 2026-07-21 | BRANCACCIO JOHN P Director | Grant or award | +5,000 | $1.48 | $7K | 35,201 |
| 2026-07-21 | Mantelli Flavio CHIEF MEDICAL OFFICER | Grant or award | +20,000 | $1.40 | $28K | 20,000 |
| 2026-07-20 | CERRONE GABRIELE M Director | Purchase | +25,000 | $1.40 | $35K | 10,851,416 |
| 2026-07-20 | CERRONE GABRIELE M Director | Grant or award | +25,000 | $1.40 | $35K | 10,851,416 |
| 2026-06-08 | Denoyer Bernard Director | Grant or award · Option | +3,500 | $1.85 | $6K | 35,190 |
| 2026-06-08 | BRANCACCIO JOHN P Director | Grant or award · Option | +6,500 | $1.85 | $12K | 138,394 |
| 2026-06-08 | Simon Willy Jules Director | Grant or award · Option | +6,500 | $1.85 | $12K | 135,502 |
| 2026-06-08 | Shah Keeren Rameshchandra Chief Financial Officer | Grant or award · Option | +40,000 | $1.85 | $74K | 544,819 |
| 2026-06-08 | CERRONE GABRIELE M Director | Grant or award | +300,000 | $1.72 | $516K | 10,826,416 |
| 2023-10-27 | CERRONE GABRIELE M Executive Chairman | Other acquisition | +70,071 | $1.50 | $105K | 9,177,903 |
Page 1 of 2 · 27 trades